PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Active compounds against Alzheimer's disease: New insights thanks to simulations

2012-01-13
(Press-News.org) More than half of all cases of dementia in the elderly can be attributed to Alzheimer's disease. Despite vast research efforts, an effective therapy has not been developed, and treatment consists of dealing with the symptoms. Changes in brain tissues are a hallmark of Alzheimer's. In affected individuals, small protein fragments known as amyloid beta peptides accumulate and are deposited in the gray brain matter. Researchers recently identified a series of synthetic compounds (inhibitors) that interfere with the self-assembly of the amyloid beta peptide in vitro; they influence both early stages and the transition to the characteristic amyloid fibrils. On a theoretical level, these compounds thus satisfy an initial condition for the development of an Alzheimer drug.

Peptide's disorder determines interaction

In order to understand the interactions between the amyloid beta peptide and active compounds at a structural level, Marino Convertino, Andreas Vitalis, and Amedeo Caflisch from the University of Zurich's Department of Biochemistry simulated these interactions on the computer. In doing so, they focused on a fragment of the peptide that is thought to control both interactions with inhibitors and progression of disease. Based on these simulations, the biochemists were able to identify a hierarchy of interaction patterns between the peptide and various active compounds. To their surprise, they discovered that the disordered structure of the peptide controls the interactions. "The peptide's disorder and flexibility enable it to adapt to many basic structural frameworks," explains Andreas Vitalis. Often it is only subparts of the molecules that mediate interactions on the compound side. However, even minimal changes to a compound may induce measurable changes to the peptide-compound interactions. "Design of active compounds that influence the amyloid beta peptide structurally in a specific manner will only be possible with the aid of high-resolution methods that are limited to one or a few molecules," concludes Vitalis. In the next step, the researchers from the University of Zurich want to identify new classes of active substances with controllable properties that interact with the amyloid beta peptide.

INFORMATION:

Further reading: Marino Convertino, Andreas Vialis, Amadeo Caflisch. Disordered Binding of Small Molecules to Aβ(12-28). Journal of Biological Chemistry. October 3, 2011. doi: 10.1074/jbc.M111.285957

The study was funded by the Swiss National Science Foundation and University of Zurich research credit.

Contact:
Dr. Andreas Vitalis
Department of Biochemistry
University of Zurich
Tel.: +41 44 635 55 97
Email: a.vitalis@bioc.uzh.ch

END



ELSE PRESS RELEASES FROM THIS DATE:

Astronomers release unprecedented data set on celestial objects that brighten and dim

Astronomers release unprecedented data set on celestial objects that brighten and dim
2012-01-13
PASADENA, Calif.—Astronomers from the California Institute of Technology (Caltech) and the University of Arizona have released the largest data set ever collected that documents the brightening and dimming of stars and other celestial objects—two hundred million in total. The night sky is filled with objects like asteroids that dash across the sky and others—like exploding stars and variable stars—that flash, dim, and brighten. Studying such phenomena can help astronomers better understand the evolution of stars, massive black holes in the centers of galaxies, and the ...

Caltech chemists devise chemical reaction that holds promise for new drug development

Caltech chemists devise chemical reaction that holds promise for new drug development
2012-01-13
PASADENA, Calif. -- A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules. The reaction they have come up with should enable chemists to synthesize new varieties of a whole subclass of organic compounds called nitrogen-containing heterocycles, thus opening up new avenues for the development of novel pharmaceuticals and natural products ranging from chemotherapeutic compounds to bioactive plant materials such as morphine. The team—led by Brian Stoltz, the Ethel Wilson Bowles and Robert Bowles Professor ...

La Jolla Institute researchers identify pivotal immune cell in Type 1 diabetes in humans

2012-01-13
SAN DIEGO – (January 12, 2012) Researchers at the La Jolla Institute for Allergy & Immunology have proven – for the first time in human tissues -- the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas. The finding is an important advance that verifies in humans several important disease characteristics shown in mouse studies and provides a key focal point for interrupting the disease process. "This study marks the first time that the presence of beta cell-reactive T cells has been directly proven in pancreas tissues from ...

Girl power surges in India

2012-01-13
EVANSTON, Ill. --- By putting 18 million cracks in the proverbial glass ceiling, Hillary Clinton changed the way Americans think about women in politics, and new Northwestern University research suggests that an affirmative action law in India is doing the same for Indian women. The research, to be published Jan. 12 in the journal Science, focused on the long-term outcomes of a law that reserved leadership positions for women in randomly selected village councils in India. The law has led to a direct role model effect and is changing the way the girls as well as their ...

VTT: One-third of car fuel consumption is due to friction loss

2012-01-13
No less than one third of a car's fuel consumption is spent in overcoming friction, and this friction loss has a direct impact on both fuel consumption and emissions. However, new technology can reduce friction by anything from 10% to 80% in various components of a car, according to a joint study by VTT Technical Research Centre of Finland and Argonne National Laboratory (ANL) in USA. It should thus be possible to reduce car's fuel consumption and emissions by 18% within the next 5 to 10 years and up to 61% within 15 to 25 years. There are 612 million cars in the world ...

Expectant mothers on antidepressants risk newborns with high blood pressure

2012-01-13
Mothers who take anti-depressants during pregnancy are more likely to give birth to children with persistent pulmonary hypertension (high blood pressure in the lungs) finds a study published today on bmj.com. Persistent pulmonary hypertension is an increase in blood pressure in the lungs leading to shortness of breath and difficulty breathing. It is a rare, but severe disease with strong links to heart failure. The study, carried out by researchers at the Centre for Pharmacoepidemiology at Karolinska Institutet in Stockholm Sweden, reviewed 1.6 million births in total ...

Mass media and health: Well-informed people eat better

2012-01-13
It is time to leave apart the belief that mass media are always a source of bad habits. Television, newspaper and the Internet, when used to get information, may turn out to be of help for health. It is the conclusion of a study conducted by the Research Laboratories at the Fondazione di Ricerca e Cura "Giovanni Paolo II" in Campobasso which analyzed data from a sample of more than 1,000 people from the largest Moli-sani Project, the epidemiological study that recruited 25,000 subjects in Molise, a southern region of Italy. The report, published on line in the International ...

New laboratory method uses mass spectrometry to rapidly detect staph infections

New laboratory method uses mass spectrometry to rapidly detect staph infections
2012-01-13
Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus. Quickly and accurately detecting infections caused by S. aureus is critical because the pathogenic bacterium causes a broad spectrum of infections, ranging from acute to chronic disease, which need to ...

Hydrogen advances graphene use

2012-01-13
Physicists at Linköping University have shown that a dose of hydrogen or helium can render the "super material" graphene even more useful. Graphene has engendered high expectations whereof its extreme properties depend on the fact that it consists of a single sheet of carbon atoms. However the attraction forces between the atoms cause the sheets to be drawn to each other. One solution is to add atomic hydrogen between the layers. Presented in the eminent journal Physical Review A, the researchers' calculations show that the hydrogen at a given concentration affects ...

Thousands of seniors lack access to lifesaving organs, despite survival benefit

2012-01-13
Thousands more American senior citizens with kidney disease are good candidates for transplants and could get them if physicians would get past outdated medical biases and put them on transplant waiting lists, according to a new study by Johns Hopkins researchers. The Hopkins investigators estimate that between 1999 and 2006, roughly 9,000 adults over 65 would have been "excellent" transplant candidates and approximately 40,000 more older adults would have been "good" candidates for new kidneys. None, however, were given the chance. "Doctors routinely believe and tell ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Active compounds against Alzheimer's disease: New insights thanks to simulations